Home›Companies›Biotech & Pharma›60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals, Inc.

Updated Oct 27, 2026·Latest SEC filing May 24, 2023·Suggest an edit

About 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals is a private company based in Washington, District of Columbia, incorporated in 2022 in Delaware. It has reported $1,755,000 raised in one offering on Form D since May 2023. Its chief executive is Geoffrey Dow.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 19, 2022May 24, 2023$1,755,000target not set10$175KEquity, DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on 60 Degrees Pharmaceuticals's Form D filed May 24, 2023.

GD
Geoffrey Dow
Chief Executive Officer and President, director

Sources

  1. SEC60 DEGREES PHARMACEUTICALS, INC. filing history